August 31, 2026- Insulin, a manufactured type of hormone that patients with diabetes use to manage their condition, was discovered more than 100 years ago. While insulin therapy for patients with diabetes is lifesaving, it is not a cure. Today, it remains the only treatment option for the disease.
Despite the many medical advances in diabetes treatment over the years, its diagnosis in the U.S. has increased from under 1% in 1957, to one in ten Americans currently living with diabetes today, according to the American Diabetes Association (ADA). The cost of treating diagnosed diabetes in the U.S. is a staggering $245 billion each year, per the ADA.
Researchers have made progress in the prevention, diagnosis and treatment of diabetes, but ongoing funding and resource constraints have led to disparities in research talent, with many early-career researchers entering the industry to find that research dollars are scarce.
Designed to address these challenges, the ADA launched the Pathway to Stop Diabetes® program in 2014. The program provides flexible, long-term funding that empowers scientists to pursue bold, new ideas without the constraints of traditional project-based grants.
Continue Reading in the latest issue of Repertoire Magazine.